XML 55 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Details 1) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Components of Deferred Tax Assets [Abstract]    
Net operating loss carry forwards $ 31,216,000 $ 29,594,000
Orphan drug and research and development credit carry forwards 4,909,000 3,556,000
Equity based compensation 1,923,000 2,049,000
Intangibles 2,090,000 2,140,000
Total 40,138,000 37,339,000
Valuation allowance (40,138,000) (37,339,000)
Net deferred tax assets